Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: J&J v. Millenson

This article was originally published in The Gray Sheet

Executive Summary

J&J v. Millenson: Arbitrator determines Johnson & Johnson's premarket submission in France violated a milestone payment agreement in former Direct Access Diagnostic President and CEO Elliot Millenson's contract. As a result of the decision, J&J agrees to pay Millenson $500,000 for his role in developing the Confide home HIV test system. Millenson and J&J also are involved in ongoing litigation in New Jersey Superior Court over ownership of DAD ("The Gray Sheet" Aug. 5, p. 10). A court date to determine whether J&J will have to relinquish all DAD assets to Millenson has been set for Oct. 16...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT006723

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel